Regional but Fatal: Intraperitoneal Metastasis in Gastric Cancer

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2016 Sep 28

PMID 27672270

Citations 40

Authors

Jia Wei

Nan-Die Wu

Bao-Rui Liu

Affiliations

Soon will be listed here.

Abstract

Peritoneal carcinomatosis appears to be the most common pattern of metastasis or recurrence and is associated with poor prognosis in gastric cancer patients. Many efforts have been made to improve the survival in patients with peritoneal metastasis. Hyperthermic intraperitoneal chemotherapy remains a widely accepted strategy in the treatment of peritoneal dissemination. Several phase II-III studies confirmed that the combined cytoreducitve surgery and hyperthermic intraperitoneal chemotherapy resulted in longer survival in patients with peritoneal carcinomatosis. In addition, proper selection and effective regional treatment in patients with high risk of peritoneal recurrence after resection will further improve prognosis in local advanced gastric cancer patients.

Citing Articles

Identification of gastric cancer subtypes based on disulfidptosis-related genes: GPC3 as a novel biomarker for prognosis prediction.

Yi N, Yin X, Feng X, Ren M, Ma C Discov Oncol. 2024; 15(1):810.

PMID: 39695020 PMC: 11655940. DOI: 10.1007/s12672-024-01694-7.

Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors.

Johannet P, Abdelfattah S, Wilde C, Patel S, Walch H, Rousseau B J Clin Oncol. 2024; 42(32):3847-3857.

PMID: 39121438 PMC: 11540749. DOI: 10.1200/JCO.24.00186.

Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort study.

Tao J, Zhang Y, Wang Y, Huang S, Gao W, Dai L J Gastrointest Oncol. 2024; 15(2):630-640.

PMID: 38756629 PMC: 11094490. DOI: 10.21037/jgo-24-76.

Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea: A Systematic Literature Review.

Zhang X, Zhou L, Zhou C, Shen L Adv Ther. 2024; 41(6):2112-2132.

PMID: 38619719 PMC: 11133076. DOI: 10.1007/s12325-024-02838-5.

Peritoneal Washing Cytology Positivity in Gastric Cancer: Role of Lymph Node Metastasis as a Risk Factor.

Kim S, Lee H, Song K, Seo H J Gastric Cancer. 2024; 24(2):185-198.

PMID: 38575511 PMC: 10995825. DOI: 10.5230/jgc.2024.24.e14.

References

Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Ohashi N, Yamamura Y . Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: analysis of real time reverse transcriptase-polymerase chain reaction after 5 years of followup. J Am Coll Surg. 2006; 202(2):231-6. DOI: 10.1016/j.jamcollsurg.2005.09.008. View

Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R . EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer. 2009; 45(6):931-91. DOI: 10.1016/j.ejca.2008.11.018. View

Fushida S, Kinoshita J, Kaji M, Hirono Y, Goda F, Yagi Y . Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis. Cancer Chemother Pharmacol. 2013; 71(5):1265-72. PMC: 3636429. DOI: 10.1007/s00280-013-2122-0. View

Ishigami H, Kitayama J, Kaisaki S, Hidemura A, Kato M, Otani K . Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol. 2009; 21(1):67-70. DOI: 10.1093/annonc/mdp260. View

Yonemura Y, Endou Y, Fujita H, Fushida S, Bandou E, Taniguchi K . Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric Cancer. 2002; 3(2):63-70. DOI: 10.1007/pl00011698. View

Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Hiramoto H . Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy. Ann Surg Oncol. 2014; 22(3):758-64. DOI: 10.1245/s10434-014-4060-4. View

To E, Chan W, Chow C, Ng E, Chung S . Gastric cancer cell detection in peritoneal washing: cytology versus RT-PCR for CEA transcripts. Diagn Mol Pathol. 2003; 12(2):88-95. DOI: 10.1097/00019606-200306000-00004. View

Leake P, Cardoso R, Seevaratnam R, Lourenco L, Helyer L, Mahar A . A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Cancer. 2011; 15 Suppl 1:S27-37. DOI: 10.1007/s10120-011-0071-z. View

Chambers S, Chow H, Janicek M, Cragun J, Hatch K, Cui H . Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer. Clin Cancer Res. 2012; 18(9):2668-78. PMC: 3343173. DOI: 10.1158/1078-0432.CCR-12-0261. View

10.

Yoo C, Ryu M, Park Y, Yoo M, Park S, Ryoo B . Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence. Ann Surg Oncol. 2015; 22(9):2940-7. DOI: 10.1245/s10434-014-4352-8. View

11.

Eppink B, Krawczyk P, Stap J, Kanaar R . Hyperthermia-induced DNA repair deficiency suggests novel therapeutic anti-cancer strategies. Int J Hyperthermia. 2012; 28(6):509-17. DOI: 10.3109/02656736.2012.695427. View

12.

Sha H, Zou Z, Xin K, Bian X, Cai X, Lu W . Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy. J Control Release. 2015; 200:188-200. PMC: 5008032. DOI: 10.1016/j.jconrel.2014.12.039. View

13.

Kang K, Hur H, Byun C, Kim Y, Han S, Cho Y . Conventional cytology is not beneficial for predicting peritoneal recurrence after curative surgery for gastric cancer: results of a prospective clinical study. J Gastric Cancer. 2014; 14(1):23-31. PMC: 3996246. DOI: 10.5230/jgc.2014.14.1.23. View

14.

Roviello F, Marrelli D, Neri A, Cerretani D, De Manzoni G, Pedrazzani C . Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg. 2006; 30(11):2033-40. DOI: 10.1007/s00268-006-0038-0. View

15.

Kowalewska M, Chechlinska M, Nowak R . Carcinoembryonic antigen and cytokeratin 20 in peritoneal cells of cancer patients: are we aware of what we are detecting by mRNA examination?. Br J Cancer. 2008; 98(2):512-3. PMC: 2361435. DOI: 10.1038/sj.bjc.6604189. View

16.

Desai A, Hawksworth G . Cryopreservation of rat hepatocytes with high attachment efficiency and mixed function oxidase activity post thawing. Biochem Soc Trans. 1990; 18(6):1214. DOI: 10.1042/bst0181214. View

17.

Graziosi L, Marino E, Donini A . Role of CRS plus HIPEC in gastric cancer peritoneal carcinomatosis. J Surg Oncol. 2014; 111(2):248. DOI: 10.1002/jso.23789. View

18.

Oshima T, Yamada R, Hatori S, Kunisaki C, Imada T . Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer. Oncol Rep. 2006; 16(2):361-6. View

19.

Eom B, Yoon H, Ryu K, Lee J, Cho S, Lee J . Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg. 2010; 27(6):481-6. DOI: 10.1159/000320691. View

20.

Bai F, Wang N, Wang J, Yang L, Zhang F, Yin F . Screening and identification of peritoneal metastasis-related genes of gastric adenocarcinoma using a cDNA microarray. Genet Mol Res. 2012; 11(2):1682-9. DOI: 10.4238/2012.June.25.1. View